Biomarin Pharmaceutical Inc (BMRN)
66.60
+0.71
(+1.08%)
USD |
NASDAQ |
Nov 01, 16:00
66.60
0.00 (0.00%)
After-Hours: 20:00
Biomarin Pharmaceutical Total Liabilities (Quarterly): 1.438B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.438B |
| June 30, 2024 | 1.781B |
| March 31, 2024 | 1.799B |
| December 31, 2023 | 1.890B |
| September 30, 2023 | 1.861B |
| June 30, 2023 | 1.780B |
| March 31, 2023 | 1.775B |
| December 31, 2022 | 1.772B |
| September 30, 2022 | 1.696B |
| June 30, 2022 | 1.641B |
| March 31, 2022 | 1.671B |
| December 31, 2021 | 1.739B |
| September 30, 2021 | 1.711B |
| June 30, 2021 | 1.657B |
| March 31, 2021 | 1.643B |
| December 31, 2020 | 1.742B |
| September 30, 2020 | 2.104B |
| June 30, 2020 | 2.065B |
| March 31, 2020 | 1.483B |
| December 31, 2019 | 1.568B |
| September 30, 2019 | 1.484B |
| June 30, 2019 | 1.432B |
| March 31, 2019 | 1.499B |
| December 31, 2018 | 1.459B |
| September 30, 2018 | 1.780B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.740B |
| March 31, 2018 | 1.790B |
| December 31, 2017 | 1.824B |
| September 30, 2017 | 1.767B |
| June 30, 2017 | 1.224B |
| March 31, 2017 | 1.170B |
| December 31, 2016 | 1.257B |
| September 30, 2016 | 1.196B |
| June 30, 2016 | 1.170B |
| March 31, 2016 | 1.377B |
| December 31, 2015 | 1.329B |
| September 30, 2015 | 1.332B |
| June 30, 2015 | 1.292B |
| March 31, 2015 | 1.233B |
| December 31, 2014 | 947.48M |
| September 30, 2014 | 931.99M |
| June 30, 2014 | 883.72M |
| March 31, 2014 | 880.61M |
| December 31, 2013 | 903.02M |
| September 30, 2013 | 344.04M |
| June 30, 2013 | 343.26M |
| March 31, 2013 | 348.14M |
| December 31, 2012 | 552.58M |
| September 30, 2012 | 552.18M |
| June 30, 2012 | 532.10M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.438B
Minimum
Sep 2024
2.104B
Maximum
Sep 2020
1.741B
Average
1.741B
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co Inc | 68.98B |
| Bristol-Myers Squibb Co | 76.47B |
| Alnylam Pharmaceuticals Inc | 4.173B |
| Bioventus Inc | 603.11M |
| Moderna Inc | 3.968B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.851B |
| Shareholders Equity (Quarterly) | 5.413B |
| Debt to Equity Ratio | 0.1098 |
| Current Ratio | 4.271 |
| Net Debt Paydown Yield | 0.73% |